Back | Next |
home / stock / gild / gild message board
Subject | By | Source | When |
---|---|---|---|
Gilead Sciences Inc ($GILD) | mick | investorshub | 03/12/2022 8:03:28 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 02/15/2022 9:33:38 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 02/06/2022 10:27:48 PM |
$GILD owes ViiV* $1.25B+ 3% royalty on US Biktarvy sales, | DewDiligence | investorshub | 02/02/2022 12:04:10 AM |
$GILD 4Q21 results | DewDiligence | investorshub | 02/01/2022 9:08:45 PM |
https://www.otcmarkets.com/stock/$GILD | mick | investorshub | 01/02/2022 11:12:00 PM |
GILD vs $BMY in LBCL$ CAR-Twho has the edge? | DewDiligence | investorshub | 12/14/2021 12:04:16 AM |
https://www.otcmarkets.com/stock/$GILD | mick | investorshub | 12/12/2021 12:17:35 AM |
$GILD and$ MTNB have been working on ORAL | dhbuzz | investorshub | 12/09/2021 4:13:41 PM |
VIR/$GILD start phase-2 trial testing quadruple regimen of | DewDiligence | investorshub | 12/09/2021 3:06:27 PM |
I Agree: https://www.griproom.com/fun/pfizers-covid-pill-might-not-be-as-great-a | Michel | investorshub | 11/08/2021 12:09:56 PM |
Showtime this week! Brilacidin is a BEAST. Remdesivir | Ultimate01 | investorshub | 11/08/2021 12:05:18 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 11/07/2021 5:27:25 PM |
i think so they got ah good pipeline though | mick | investorshub | 11/07/2021 5:27:17 PM |
http://www.ipharminc.com/press-release/2020/9/15/laboratory-testing-of-brilacidi | Michel | investorshub | 11/02/2021 11:33:38 AM |
Mick, I think we are the only ones | slimhere | investorshub | 10/29/2021 2:36:58 PM |
$15 under wow | mick | investorshub | 10/28/2021 9:11:11 PM |
Gilead Sciences Inc ($GILD) | mick | investorshub | 10/28/2021 9:10:40 PM |
5PM, we'll see how close you are, I'm | slimhere | investorshub | 10/28/2021 7:09:44 PM |
$gild should be over $80 to $100 imho | mick | investorshub | 10/10/2021 4:18:04 PM |
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / July 1, 2024 / Jim Candler had a successful 40-year career in system operations before coming to Gilead three years ago to bring his tech expertise to the Human Resources team. "I was hired at 71 years old. What does that say about Gilead?" says Jim, Senior Direct...
2024-07-01 06:50:00 ET Most retirees prefer low turnover in their investment portfolios. The less drama, the better. That way, they can focus on doing what they enjoy instead of worrying about their investments. Three Motley Fool contributors think they've found magnificent stocks retir...
2024-06-24 13:00:04 ET Michael Yee from Jefferies issued a price target of $85.00 for GILD on 2024-06-24 10:57:00. The adjusted price target was set to $85.00. At the time of the announcement, GILD was trading at $71.24. The overall price target consensus is at $80.71 wi...